Mark Cuban: Pharma’s Secret Weapon In The Fight Against PBMs

The well-known businessman and TV personality told the White House that the US needs to ‘stop doing business with the big three PBMs,’ helping to fight the drug industry’s battle against the middlemen with a friendlier face not associated directly with the brand industry.

Mark Cuban at White House on 4 March 2024 — Mark Cuban was part of a White House panel on PBM issues that did not include any PBMs. • Source: Screenshot of White House feed

The pharmaceutical industry wasn’t directly represented at the White House’s pharmacy benefits management roundtable on 4 March, but their agenda – to put the onus of drug affordability challenges on PBMs – took center stage, offered by actors who likely make the industry’s messages more palatable.

The big three PBMs, as they were called during the discussion titled to “bring transparency to prescription drug middlemen,” weren’t...